| Dr Christian Davis Capanna, MD | |
|
11700 N Meridian St, Carmel, IN 46032-4656 | |
| (317) 880-3800 | |
| (317) 880-0545 |
| Full Name | Dr Christian Davis Capanna |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 6 Years |
| Location | 11700 N Meridian St, Carmel, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962995118 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 01085167A (Indiana) | Secondary |
| 207P00000X | Emergency Medicine | 125.073037 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Vincent Hospital | Indianapolis, IN | Hospital |
| Crawford Memorial Hospital | Robinson, IL | Hospital |
| Ascension St Vincent Mercy | Elwood, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Crawford Hospital District | 7719898071 | 60 |
News Archive
Synergy Pharmaceuticals Inc. today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and once-daily oral treatment, in adult patients with chronic idiopathic constipation.
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of a research study describing the technology behind the Vanadis NIPT system.
New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to please donate blood in honor and remembrance of the thousands of men, women, and children affected by the terrorist attacks of September 11, 2001. Each pint of blood donated can potentially save the lives of three people through the use of blood and blood products.
A 24-hour rhythm of cellular detoxification in flies and mammals is coordinated by a neuropeptide that also drives feeding in both organisms, found a team led by Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program, in the Perelman School of Medicine at the University of Pennsylvania.
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
› Verified 5 days ago
| Entity Name | Crawford Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861423287 PECOS PAC ID: 7719898071 Enrollment ID: O20040205000950 |
News Archive
Synergy Pharmaceuticals Inc. today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and once-daily oral treatment, in adult patients with chronic idiopathic constipation.
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of a research study describing the technology behind the Vanadis NIPT system.
New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to please donate blood in honor and remembrance of the thousands of men, women, and children affected by the terrorist attacks of September 11, 2001. Each pint of blood donated can potentially save the lives of three people through the use of blood and blood products.
A 24-hour rhythm of cellular detoxification in flies and mammals is coordinated by a neuropeptide that also drives feeding in both organisms, found a team led by Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program, in the Perelman School of Medicine at the University of Pennsylvania.
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
› Verified 5 days ago
| Entity Name | Cepamerica Illinois Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912283110 PECOS PAC ID: 3274793633 Enrollment ID: O20120322000587 |
News Archive
Synergy Pharmaceuticals Inc. today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and once-daily oral treatment, in adult patients with chronic idiopathic constipation.
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of a research study describing the technology behind the Vanadis NIPT system.
New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to please donate blood in honor and remembrance of the thousands of men, women, and children affected by the terrorist attacks of September 11, 2001. Each pint of blood donated can potentially save the lives of three people through the use of blood and blood products.
A 24-hour rhythm of cellular detoxification in flies and mammals is coordinated by a neuropeptide that also drives feeding in both organisms, found a team led by Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program, in the Perelman School of Medicine at the University of Pennsylvania.
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christian Davis Capanna, MD 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Dr Christian Davis Capanna, MD 11700 N Meridian St, Carmel, IN 46032-4656 Ph: (317) 880-3800 |
News Archive
Synergy Pharmaceuticals Inc. today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and once-daily oral treatment, in adult patients with chronic idiopathic constipation.
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of a research study describing the technology behind the Vanadis NIPT system.
New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, calls upon the communities it serves to please donate blood in honor and remembrance of the thousands of men, women, and children affected by the terrorist attacks of September 11, 2001. Each pint of blood donated can potentially save the lives of three people through the use of blood and blood products.
A 24-hour rhythm of cellular detoxification in flies and mammals is coordinated by a neuropeptide that also drives feeding in both organisms, found a team led by Amita Sehgal, PhD, a professor of Neuroscience and director of the Chronobiology Program, in the Perelman School of Medicine at the University of Pennsylvania.
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
› Verified 5 days ago
Dr. Jack K Keene, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 11700 N Meridian St, Carmel, IN 46032 Phone: 317-688-3140 Fax: 317-688-2664 | |
Dr. Paula Lange, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3252 Tantara Bnd, Carmel, IN 46032 Phone: 317-733-8252 | |
Dr. Matthew N Negaard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10767 Illinois St Ste 3000, Carmel, IN 46032 Phone: 317-817-1200 Fax: 317-817-1220 | |
Sean Tokita, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 13500 N Meridian St, Carmel, IN 46032 Phone: 626-354-3195 | |
Dr. Rachel Marie White, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11700 N Meridian St, Carmel, IN 46032 Phone: 317-688-3140 | |
Dr. Rodney Eugene Corson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10921 Lakeview Dr, Carmel, IN 46033 Phone: 317-844-8203 | |
Sean M Trivedi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 11700 N Meridian St, Emergency Department, Carmel, IN 46032 Phone: 317-688-3139 Fax: 317-688-2664 |